%0 Journal Article %T Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma %A Christel Herold-Mende %A Denis Migliorini %A Eliana Marinari %A Giulia Ranzanici %A Hideho Okada %A Johannes Alexander Lobrinus %A Joseph Costello %A Paul R. Walker %A Pierre-Yves Dietrich %A Shahan Momjian %A Toni Weinschenk %A Val¨Śrie Dutoit %A Val¨Śrie Widmer %J Archive of "Oncoimmunology". %D 2018 %R 10.1080/2162402X.2017.1391972 %K grade II glioma %K grade III glioma %K immunotherapy %K peptide vaccine %K IMA950 %K spontaneous T cell responses %K astrocytoma %K oligodendroglioma %K ependymoma %U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749651/